HAE - Haemonetics Corporation (HAE) Q1 2026 Earnings Call Transcript

2025-08-09 22:53:19 ET

Haemonetics Corporation (HAE)

Q1 2026 Earnings Conference Call

August 07, 2025 08:00 AM ET

Company Participants

Christopher A. Simon - CEO, President & Director

James C. D'Arecca - CFO, Executive VP & Financial Officer

Olga Guyette - Senior Director of Investor Relations

Conference Call Participants

Andrew Harris Cooper - Raymond James & Associates, Inc., Research Division

Anthony Charles Petrone - Mizuho Securities USA LLC

Rohin Kirit Patel - JPMorgan Chase & Co

David Kenneth Rescott - Unidentified Company

Citizens JMP - Unidentified Company

Lawrence Scott Solow - CJS Securities, Inc.

Marie Yoko Thibault - BTIG, LLC, Research Division

Michael John Petusky - Barrington Research Associates, Inc., Research Division

Michael Stephen Matson - Needham & Company, LLC, Research Division

Presentation

Operator

Good day, and thank you for standing by. Welcome to the Haemonetics Corporation First Quarter 2026 Earnings Call. [Operator Instructions]. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Olga Guyette, Vice President, Investor Relations and Treasury. Olga, you have the floor.

Olga Guyette

Good morning, and thank you for joining us for Haemonetics' First Quarter Fiscal Year 2020 conference call and webcast. I'm joined today by Chris Simon, our CEO; and James D'Arecca, our CFO. This morning, we posted our first quarter fiscal year 2026 results and full year fiscal 2026 guidance to our Investor Relations website. The same information was made available via the press release issued this morning. As we provide our business and financial update this morning, I would like to remind everyone that we will use both reported and organic revenue growth numbers that exclude the impact of FX, the divestiture of the whole blood business and the exit of liquid solution products. Organic revenue growth ex CSL also excludes the impact of the previously discussed transition of CSL's U.S. disposables business....

For further details see: